{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:03:14Z","timestamp":1783105394854,"version":"3.54.6"},"reference-count":19,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T00:00:00Z","timestamp":1488240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Neuroscience Research"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>The claudin family comprises four\u2010pass transmembrane proteins involved in the formation of tight junctions (TJs). Relatively recently, claudin domain containing (CLDND) 1, also known as claudin\u201025, was identified as a novel member of the claudin family. In the present study, we revealed that in the adult murine brain, CLDND1 is abundant in the cerebellum among common sites of intracerebral hemorrhage. Thus, the dynamics of CLDND1 after cerebellar hemorrhage were examined. Both CLDND1 mRNA and protein levels transiently decreased at 24\u2009hr after hemorrhagic insult. For immunostaining, an anti\u2010CLDND1 antibody that recognizes the specific epitope in the extracellular first loop was prepared. Dual immunohistochemical staining with CD31 using coronal cryosections of intact murine cerebellum tissue revealed that CLDND1 is expressed on endothelial cells. We therefore performed an in vitro permeability test using a human brain endothelial cell (HBEC) line to reveal whether CLDND1 contributes to cell adhesion like other claudins. CLDND1 was expressed on HBECs as well as in murine cerebellum tissue, and a strong signal was observed at TJs. RNA interference against CLDND1 decreased both the mRNA and protein levels without cytotoxicity. The permeability to small molecules, but not to large ones, across confluent HBECs increased on CLDND1 knockdown compared with mock\u2010treated cells. These results suggest that the transient decrease of CLDND1 after cerebellar hemorrhage is responsible for low\u2010molecular\u2010weight selective vascular hyperpermeability. \u00a9 2017 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/jnr.24040","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T06:03:05Z","timestamp":1488261785000},"page":"2051-2058","source":"Crossref","is-referenced-by-count":27,"title":["Claudin domain containing 1 contributing to endothelial cell adhesion decreases in presence of cerebellar hemorrhage"],"prefix":"10.1002","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9832-0990","authenticated-orcid":false,"given":"Masatoshi","family":"Ohnishi","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapeutics, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapeutics, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapeutics, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Akagi","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapeutics, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapeutics, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiho","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Uda","sequence":"additional","affiliation":[{"name":"Department of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kamishikiryo","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Michihara","sequence":"additional","affiliation":[{"name":"Department of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapeutics, Faculty of Pharmacy and Pharmaceutical Sciences Fukuyama University Higashimura\u2010cho, Fukuyama Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130300"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1852"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0284-x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(02)00507-3"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.09.049"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E07-09-0973"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.141.7.1539"},{"key":"e_1_2_9_9_1","first-page":"2","article-title":"Identification of cerebral infarction\u2010specific antibody markers from autoantibodies detected in patients with systemic lupus erythematosus","volume":"6","author":"Goto K","year":"2015","journal-title":"J Mol Biomark Diagn"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00019.2012"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2011.202"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.01.028"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.11.013"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-007-0274-x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200302070"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2007.03.030"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.06.026"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-8319com"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-011-0626-8"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201400159"}],"container-title":["Journal of Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjnr.24040","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jnr.24040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T18:12:16Z","timestamp":1696356736000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jnr.24040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1002\/jnr.24040"],"URL":"https:\/\/doi.org\/10.1002\/jnr.24040","archive":["Portico"],"relation":{},"ISSN":["0360-4012","1097-4547"],"issn-type":[{"value":"0360-4012","type":"print"},{"value":"1097-4547","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]}}}